How Polygenic Risk Scores are Transforming Health

20 February 2025

Genomics and Precision Medicine

Arab Health 2025

About the Speakers

Dr. Vidya Velagapudi

Senior Vice President, Precision Medicine and Academy of Education & Research, Global Patient Care platform, M42
Dr. Javier Quilez

Associate Director - Bioinformatics for M42
Dr. Fawad Khan

Program Lead of the Hereditary High Risk & Cancer Survivorship Programs at the Oncology Institute, Cleveland Clinic Abu Dhabi
Dr. Stephen Grobmyer

Chairman of Oncology at Cleveland Clinic Abu Dhabi
Paul Jones

Chief Executive Officer, Omics Centre of Excellence

Paul Jones, CEO of M42’s Omics Centre of Excellence, drives advancements in genomics and precision medicine with 30+ years of experience in global genomic programs and personalized health solutions.